On August 21, 2024, Gilead registered a Phase I clinical trial for its small-molecule GLP-1 receptor agonist GS-4571 for diabetes and obesity treatment on ClinicalTrials.gov
The Western IRB granted TriNetX a waiver because its federated design ensures that only aggregated, de-identified summary data are shared externally
Left unchecked, GLP-1 costs will crush your pharmacy spend and drive up health plan premiums, stop-loss rates, and employee contributions
Furthermore, metabolic needs are very specific during these periods and generally do not require supplementation
Networks, such as regulatory networks, coexpression networks, or protein-protein interaction networks, transform multiple input datasets into more comprehensible data by using global and local features of networks (Li and Gao, 2019
Oxidative stress in oocyte aging and female reproduction